GLP-1s, Explained: How These Medications Actually Work

No class of medication has changed the weight-management conversation like GLP-1 agonists. They're in headlines, in commercials, and in the questions every new client asks. And because misunderstanding runs almost as deep as the hype, here's the clinical primer — what GLP-1s are, what they do and don't do, and how they fit into our medical weight-management program.
The Mechanism, Plainly
GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after eating. The medications copy it — and slow its breakdown — so three things happen: your stomach empties more slowly (prolonged fullness), your pancreas releases insulin more efficiently when blood sugar rises, and — the effect everyone talks about — the appetite-regulating centers in your brain receive stronger satiety signals. The 'food noise' patients describe quieting? That's hypothalamic signaling, working as the FDA-approved labeling describes. This is physiology, not willpower pharmacology.
Who's Actually a Candidate
Clinical eligibility criteria follow the CDC's obesity treatment guidance: generally a BMI of 30+, or 27+ with weight-related conditions. Non-negotiables in responsible prescribing: kidney and thyroid history review, no personal or family history of medullary thyroid carcinoma or MEN2, and no history of pancreatitis. This is why a GLP-1 program that starts with a questionnaire and ends at a pharmacy is a red flag — the medication deserves a prescriber, not a checkout button. The NIDDK's weight-management resources are a solid reference for candidacy questions.
What Supervision Adds
Here's the part the mail-order era skips: dosing is gradual, side effects are manageable with the right titration plan, and monitoring matters — we check in on symptoms, adjust timing, and watch for the rare warning signs. Our $199/month GLP-1 membership includes exactly that: medication prescribed by our Medical Director, clinical oversight, and the structure that keeps the program safe. Clients who want more — nutrition coaching, training, accountability — graduate to our Total Solution tier with weekly telehealth visits led by Robert Coles.
The Honest Expectations
Clinical trials in the New England Journal of Medicine and elsewhere show meaningful average weight loss — along with the equally real caveats: results vary, side effects are common early (nausea, mainly), and the medication works only while behavior supports it. GLP-1s are a tool for a metabolic problem, not a cure for an environment. That's precisely why we built the program around labs first (here's why) and coaching always.
The Takeaway
GLP-1s are the most effective weight-management pharmacology we've ever had — in the right hands, for the right candidates, with the right structure. If you're curious whether that's you, book a consultation — the consultation is a conversation, not a commitment. You can read more about the philosophy on the weight-management page.
Jason Ward, RN
Chief Clinical Officer, Summit Elite IV & AestheticsJason Ward, RN is the co-founder and Chief Clinical Officer of Summit Elite IV & Aesthetics. A registered nurse with deep experience in infusion therapy and clinical operations, he writes about the science behind IV hydration, NAD+ and Niagen therapy, and what safe, concierge care actually looks like.








